HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance

HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance

Background: The inactivation of the tumor-suppressor homeodomain-only protein X (HOPX) usually involves promoter methylation in several cancer types. This study aimed to investigate the HOPX-β mRNA expression and promoter methylation and their clinical relevance in differentiated thyroid cancer (DTC...

Full description

Bibliographic Details
Main Authors: Erika Urbano Lima, Ileana G S Rubio, Joaquim Custodio Da Silva, Ana Luiza Galrão, Danielle Pêssoa, Taise Cerqueira Oliveira, Fabiane Carrijo, Igor Silva Campos, Luciano Fonseca Espinheira, Luiz Jose Sampaio, Claudio Rogerio Lima, Janete Maria Cerutti, Helton Estrela Ramos
Format: Article
Language:English
Published: Bioscientifica 2018-11-01
Series:Endocrine Connections
Subjects:
HOPX
methylation
differentiated thyroid cancer
epigenetic
Online Access:https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0380.xml

Internet

https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0380.xml

Similar Items